Simultaneous_JJ
activation_NN
of_IN
Ig_NN
and_CC
Oct-2_NN
synthesis_NN
and_CC
reduction_NN
of_IN
surface_NN
MHC_NN
class_NN
II_CD
expression_NN
by_IN
IL-6_NN
._.

Terminal_JJ
differentiation_NN
of_IN
B_NN
cells_NNS
to_TO
plasma_NN
cells_NNS
in_FW
vivo_FW
is_VBZ
characterized_VBN
by_IN
secretion_NN
of_IN
Ig_NN
and_CC
extinction_NN
of_IN
MHC_NN
class_NN
II_CD
expression_NN
on_IN
the_DT
cell_NN
surface_NN
._.

We_PRP
show_VBP
that_IN
IL-6_NN
signaling_NN
leads_VBZ
to_TO
marked_JJ
increases_NNS
in_IN
the_DT
synthesis_NN
and_CC
secretion_NN
of_IN
Ig_NN
in_IN
clonal_JJ
human_JJ
B_NN
cell_NN
lines_NNS
and_CC
newly_RB
isolated_VBN
polyclonal_JJ
B_NN
lymphocytes_NNS
in_FW
vitro_FW
._.

The_DT
IL-6-induced_JJ
cells_NNS
resemble_VBP
plasma_NN
cells_NNS
in_IN
ultrastructure_NN
and_CC
in_IN
reduced_VBN
expression_NN
of_IN
surface_NN
MHC_NN
class_NN
II_CD
._.

Enhanced_VBD
Ig_NN
synthesis_NN
is_VBZ
a_DT
result_NN
of_IN
coordinated_VBN
transcriptional_JJ
activation_NN
of_IN
Ig_NN
genes_NNS
without_IN
promoter_NN
or_CC
isotype_NN
specificity_NN
,_,
and_CC
differential_JJ
accumulation_NN
of_IN
the_DT
mRNA_NN
encoding_VBG
the_DT
secreted_VBN
form_NN
of_IN
Ig_NN
heavy_JJ
chain_NN
._.

It_PRP
is_VBZ
saturable_JJ
and_CC
subject_JJ
to_TO
negative_JJ
control_NN
when_WRB
IL-6_NN
stimulation_NN
is_VBZ
prolonged_JJ
._.

Coordinate_JJ
with_IN
temporal_JJ
changes_NNS
in_IN
Ig_NN
synthesis_NN
,_,
the_DT
DNA-binding_JJ
activity_NN
and_CC
the_DT
synthesis_NN
of_IN
the_DT
B_NN
cell-enriched_JJ
transcription_NN
factor_NN
Oct-2_NN
are_VBP
regulated_VBN
._.

Thus_RB
,_,
differentiation_NN
of_IN
B_NN
cells_NNS
with_IN
IL-6_NN
in_FW
vitro_FW
recapitulates_VBZ
the_DT
hallmarks_NNS
of_IN
terminal_JJ
B_NN
differentiation_NN
in_FW
vivo_FW
;_:
Oct-2_NN
may_MD
have_VB
a_DT
role_NN
in_IN
this_DT
process_NN
._.

